Anxiety · GAD-7

How anxious are you really?

Die GAD-7-Skala (Generalisierte Angststörung, 7 Items) ist das am häufigsten verwendete validierte Instrument zur Erkennung und Messung der Angstschwere. An der Columbia University entwickelt, wird sie von Klinikern weltweit eingesetzt.

⏱ 3 min ❓ 7 Fragen ✓ 100% Free
▶ Kostenlos starten
🔒 No registration · Instant results
🔬 Angst-Screening (GAD-7)
▶ Test jetzt starten
Download sample PDF →
⚠️ Haftungsausschluss: Dieses Tool dient nur zu Informationszwecken und stellt keine medizinische Diagnose dar. Wenn Angst Ihren Alltag beeinträchtigt, wenden Sie sich an einen Arzt.
Claude AI
KI-Interpretation durch Claude (Anthropic)
claude-sonnet-4-20250514
Your results are analyzed by Claude, Anthropic's AI model, which provides a personalized narrative explaining what your answers reveal about your profile, with practical recommendations and professional guidance.

📋 What to expect

Antworten Sie ehrlich Es gibt keine richtigen oder falschen Antworten
Nehmen Sie sich Zeit Lesen Sie jede Frage sorgfältig, bevor Sie antworten
KI-Interpretation Claude AI wird Ihre Ergebnisse analysieren und erklären
PDF Report Get a full PDF report of your results

What is Generalised Anxiety Disorder?

Generalised Anxiety Disorder (GAD) is characterised by excessive, persistent worry about various areas of daily life (work, health, family, finances), difficult to control and present on most days for at least 6 months. GAD affects approximately 6% of people at some point in their lives. It differs from ordinary stress by its pervasive nature, persistence, and accompanying physical symptoms (muscle tension, sleep disturbance, fatigue).

Common symptoms

GAD symptoms include: excessive and difficult-to-control worry, irritability, concentration difficulties, chronic fatigue, muscle tension, sleep disturbances, and a constant feeling of being on edge. Work-related anxiety, night-time rumination, and avoidance of stressful situations are also characteristic.

About the GAD-7

The GAD-7 is a validated anxiety screening and severity scale developed by Spitzer et al. (2006), published in Archives of Internal Medicine. It is widely used in primary care and clinical research. A score ≥ 10 is associated with moderate-to-severe GAD warranting clinical evaluation.